PubMed · 1999 · 35 citations · 0 references
MedicineCardiologyPharmacologyClinical CardiologyElectrophysiologyPediatric CardiologyAtrial ElectrophysiologyAtrial FibrillationCardiac ArrhythmiasPediatric ArrhythmiasPediatric Cardiac ElectrophysiologyPediatric CardiomyopathyAdenosine Receptor SignalingAtrial Arrhythmia MechanismsPediatric Arrhythmia Pharmacotherapy
Adenosine has become the preferred acute treatment for common types of supraventricular tachycardia because of its efficacy and safety. There have been a few reports of serious proarrhythmic events associated with its use, including the induction of atrial fibrillation in adult patients. Three instances of adenosine-induced atrial proarrhythmia (two atrial fibrillation and one atrial flutter) have been observed in children with manifest or concealed Wolff-Parkinson-White syndrome at the Hospital for Sick Children, Toronto, Ontario since 1990, which indicates a previously unreported risk of atrial arrhythmia for children as well. Because adenosine may enhance antegrade bypass tract conduction, its use carries a risk of ventricular acceleration, including progression to ventricular fibrillation. Because of such rare and potentially life-threatening adverse effects, appropriate monitoring and precautions are required during the administration of the drug to children and adults.